About Index Trending news
Analyze
Top 50 Pricing
Adimab, LLC

Adimab, LLC

Work at Adimab, LLC? Add yourself to this profile

Adimab, LLC

Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital
$14,000,000
Venture capital (Series D)
$8,200,000
Employees

Team size

50+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Adimab, LLC makes some noise.